limestone has been researched along with Cardiovascular Diseases in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.34) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (34.48) | 29.6817 |
| 2010's | 15 (51.72) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Akizawa, T; Fukagawa, M; Fukushima, M; Hirakata, H; Kagimura, T; Ogata, H | 1 |
| Aragaki, AK; Cauley, J; Howard, B; Jiang, X; Johnson, KC; Kelsey, AM; LeBlanc, ES; Manson, JE; Martin, LW; Nudy, M; OʼSullivan, DM; Payne, ME; Robbins, JA; Schnatz, PF; Shikany, JM; Stefanick, ML | 1 |
| Bell, C; Bellasi, A; Bellizzi, V; Cucciniello, E; Di Iorio, B; Molony, D; Russo, D | 1 |
| Cauley, JA; Chen, Z; Chlebowski, RT; Jackson, RD; Johnson, KC; Manson, JE; O'Sullivan, MJ; Robbins, JA; Rodabough, RJ; Wactawski-Wende, J | 1 |
| Di Iorio, B | 1 |
| Hamano, T; Obi, Y | 1 |
| Ito, T; Iwashita, Y; Shigematsu, T | 1 |
| Daskalopoulou, SS; Goltzman, D; Gorgui, J; Haddad, R; Morin, SN; Ong, AM; Wall, M; Weiler, HA | 1 |
| Akizawa, T; Fukagawa, M; Hirakata, H; Kagimura, T; Kaneda, H; Ogata, H | 1 |
| Anderson, CA; Nguyen, HA; Rifkin, DE | 1 |
| Antunes, VP; Ferreira, TD; Klein, MR; Leal, PM; Sanjuliani, AF | 1 |
| Aragaki, AK; Cauley, JA; Howard, BV; Jiang, X; Johnson, KC; LeBlanc, ES; Manson, JE; Martin, LW; Nudy, M; O'Sullivan, DM; Payne, ME; Robbins, J; Schnatz, PF; Shikany, JM; Stefanick, ML; Williams, M | 1 |
| Borel, P; Buffière, C; Buisson, C; Desmarchelier, C; Dumont, U; Halimi, C; Lairon, D; Page, D; Rémond, D; Sébédio, JL | 1 |
| Floege, J | 1 |
| Yokoyama, K | 1 |
| Hutchison, AJ; Mohammed, I | 1 |
| Adamo, EB; Altavilla, D; Atteritano, M; Bitto, A; Burnett, BP; Cancellieri, F; Cannata, ML; Corrado, F; D'Anna, R; Di Stefano, V; Frisina, A; Frisina, N; Levy, RM; Lubrano, C; Marini, H; Marini, R; Mazzaferro, S; Minutoli, L; Polito, F; Squadrito, F | 1 |
| Assimon, MM; Mousa, S; Pai, AB; Shaker, O | 1 |
| Anderson, GL; Cauley, JA; Chlebowski, RT; Datta, M; Jackson, RD; Lacroix, AZ; LeBlanc, ES; Manson, JE; Pettinger, MB; Prentice, RL; Rossouw, JE; Van Horn, L; Vitolins, MZ; Wactawski-Wende, J | 1 |
| Asmus, HG; Bommer, J; Braun, J; Brunkhorst, R; Holzer, H; Krause, R; Neumayer, HH; Raggi, P; Schulz, W | 2 |
| Bito, Y; Fujita, Y; Kasumoto, H; Komaba, K; Nishioka, M; Shibuya, K; Shin, J; Shinko, S; Yamamoto, T | 1 |
| Bellinghieri, G; Calò, LA; Monardo, P; Santoro, D; Savica, V | 1 |
| Allison, M; Dolan, NC; Greenland, P; Heckbert, SR; Heiss, G; Hsia, J; Johnson, KC; Manson, JE; Ren, H; Sidney, S; Trevisan, M | 1 |
| Blair, AT; Burke, SK; Cangiano, JL; Chasan-Taber, S; Dillon, MA; Fischer, D; Garrett, L; Ling, BN; Reed, J; Suki, WN; Zabaneh, R | 1 |
| Coburn, SP; Cole, DE; Jougleux, JL; Massé, PG; Tranchant, CC | 1 |
| Meyers, D | 1 |
| Comstock, GW | 1 |
| Crawford, MD | 1 |
9 review(s) available for limestone and Cardiovascular Diseases
| Article | Year |
|---|---|
[Treatment for CKD-MBD(Chronic Kidney Disease-Mineral and Bone Disorder)].
Topics: Bone and Bones; Bone Diseases, Metabolic; Calcimimetic Agents; Calcinosis; Calcium Carbonate; Cardiovascular Diseases; Cinacalcet; Ferric Compounds; Fractures, Bone; Humans; Minerals; Parathyroidectomy; Phosphates; Phosphorus, Dietary; Renal Insufficiency, Chronic; Risk Factors; Sevelamer | 2016 |
Nutrition Interventions in Chronic Kidney Disease.
Topics: Body Weight; Calcium Carbonate; Cardiovascular Diseases; Chelating Agents; Diet; Diet, Mediterranean; Dyslipidemias; Exercise; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperglycemia; Lanthanum; Phosphorus, Dietary; Protein-Energy Malnutrition; Renal Insufficiency, Chronic; Sodium, Dietary; Water-Electrolyte Balance | 2016 |
Calcium-containing phosphate binders in dialysis patients with cardiovascular calcifications: should we CARE-2 avoid them?
Topics: Acetates; Calcinosis; Calcium; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Humans; Phosphates; Polyamines; Randomized Controlled Trials as Topic; Renal Dialysis; Sevelamer | 2008 |
[Management of hyperphosphatemia ; phosphate-binder].
Topics: Calcinosis; Calcium Carbonate; Cardiovascular Diseases; Chronic Disease; Humans; Hyperphosphatemia; Kidney Diseases; Polyamines; Sevelamer; Vascular Diseases | 2009 |
Oral phosphate binders for the management of serum phosphate levels in dialysis patients.
Topics: Acetates; Administration, Oral; Aluminum Hydroxide; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Drug Monitoring; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Magnesium; Nephrology; Patient Education as Topic; Phosphorus; Polyamines; Practice Guidelines as Topic; Renal Dialysis; Sevelamer; Treatment Outcome | 2009 |
The effect of sevelamer hydrochloride and calcium-based phosphate binders on mortality in hemodialysis patients: a need for more research.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Clinical Trials as Topic; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Polyamines; Renal Dialysis; Sevelamer | 2010 |
Phosphate binders and management of hyperphosphataemia in end-stage renal disease.
Topics: Acetates; Aluminum Compounds; Bone Diseases, Metabolic; Calcinosis; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Central Nervous System Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Diet, Protein-Restricted; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus, Dietary; Polyamines; Renal Dialysis; Sevelamer | 2006 |
Water hardness and cardiovascular diseases.
Topics: Adult; Animals; Arteriosclerosis; Australia; Calcium Carbonate; Canada; Cardiovascular Diseases; Czechoslovakia; Dose-Response Relationship, Drug; Epidemiologic Methods; Ethnicity; Europe; Female; Hardness; Humans; Japan; Latin America; Magnesium; Male; Middle Aged; Morbidity; Mortality; Rabbits; Risk; Statistics as Topic; Swine; United Kingdom; United States; Urban Population; Water Softening; Water Supply | 1979 |
Hardness of drinking-water and cardiovascular disease.
Topics: Aged; Arteriosclerosis; Cadmium; Calcium; Calcium Carbonate; Cardiovascular Diseases; Coronary Disease; Female; Humans; Lead; Magnesium; Male; Middle Aged; Potassium; Sodium; Thrombosis; Trace Elements; Water Pollution, Chemical; Water Softening; Water Supply; Water-Electrolyte Balance | 1972 |
15 trial(s) available for limestone and Cardiovascular Diseases
| Article | Year |
|---|---|
Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial.
Topics: Aged; Calcium Carbonate; Cardiovascular Diseases; Female; Heart Disease Risk Factors; Hip Fractures; Humans; Hyperparathyroidism; Hyperphosphatemia; Incidence; Japan; Lanthanum; Male; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Survival Analysis; Vascular Calcification | 2021 |
Women's Health Initiative clinical trials: potential interactive effect of calcium and vitamin D supplementation with hormonal therapy on cardiovascular disease.
Topics: Aged; Calcium; Calcium Carbonate; Cardiovascular Diseases; Dietary Supplements; Double-Blind Method; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Postmenopause; Prospective Studies; Risk Factors; Stroke; United States; Women's Health | 2019 |
Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial.
Topics: Aged; Calcium Carbonate; Cardiovascular Diseases; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Polyamines; Renal Dialysis; Sevelamer; Single-Blind Method; Survival Rate; Time Factors | 2013 |
Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women's Health Initiative.
Topics: Aged; Breast Neoplasms; Calcium Carbonate; Calcium, Dietary; Cardiovascular Diseases; Dietary Supplements; Double-Blind Method; Female; Follow-Up Studies; Fractures, Bone; Humans; Incidence; Middle Aged; Postmenopause; Socioeconomic Factors; Time Factors; Treatment Outcome; United States; Vitamin D; Women's Health | 2013 |
Design and baseline characteristics of the LANDMARK study.
Topics: Aged; Biomarkers; Calcium Carbonate; Cardiovascular Diseases; Chelating Agents; Clinical Protocols; Disease-Free Survival; Female; Humans; Hyperphosphatemia; Japan; Lanthanum; Male; Middle Aged; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Research Design; Risk Factors; Time Factors; Treatment Outcome | 2017 |
No difference in acute effects of supplemental v. dietary calcium on blood pressure and microvascular function in obese women challenged with a high-fat meal: a cross-over randomised study.
Topics: Adult; Blood Pressure; Body Mass Index; Bone Density Conservation Agents; Brazil; Calcium; Calcium Carbonate; Calcium, Dietary; Cardiovascular Diseases; Cross-Over Studies; Dairy Products; Diet, High-Fat; Dietary Supplements; Female; Forearm; Heart Rate; Humans; Hyperemia; Microvessels; Obesity; Postprandial Period; Risk Factors | 2016 |
Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative: A Randomized Controlled Trial.
Topics: Aged; Calcium Carbonate; Calcium, Dietary; Cardiovascular Diseases; Cholecalciferol; Cholesterol, LDL; Dietary Supplements; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Risk Factors; Vitamins; Women's Health | 2017 |
Dietary calcium impairs tomato lycopene bioavailability in healthy humans.
Topics: Adult; Calcium Carbonate; Calcium, Dietary; Cardiovascular Diseases; Carotenoids; Cross-Over Studies; Dietary Supplements; Digestion; Female; France; Fruit; Humans; Incidence; Intestinal Absorption; Lycopene; Male; Meals; Micelles; Nutritive Value; Prostatic Neoplasms; Risk; Solanum lycopersicum; Surface Properties; Young Adult | 2016 |
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study.
Topics: Calcium Carbonate; Cardiovascular Diseases; Cholecalciferol; Female; Follow-Up Studies; Genistein; Homocysteine; Humans; Insulin Resistance; Lipids; Middle Aged; Osteoprotegerin; Postmenopause; Research Design; Risk Factors | 2010 |
Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study.
Topics: Aged; Bone Density Conservation Agents; Calcium Carbonate; Cardiovascular Diseases; Cholecalciferol; Dietary Supplements; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Hip Fractures; Humans; Middle Aged; Neoplasms; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Risk Assessment; United States; Urinary Calculi | 2013 |
Long-term comparison of a calcium-free phosphate binder and calcium carbonate--phosphorus metabolism and cardiovascular calcification.
Topics: Adult; Calcinosis; Calcium Carbonate; Cardiovascular Diseases; Epoxy Compounds; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Time Factors | 2004 |
Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density.
Topics: Adult; Aged; Antacids; Bone Density; Calcinosis; Calcium; Calcium Carbonate; Cardiovascular Diseases; Epoxy Compounds; Female; Humans; Male; Middle Aged; Parathyroid Hormone; Phosphates; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer | 2005 |
Calcium/vitamin D supplementation and cardiovascular events.
Topics: Aged; Calcium Carbonate; Cardiovascular Diseases; Cerebrovascular Disorders; Dietary Supplements; Female; France; Humans; Middle Aged; Postmenopause; Vitamin D | 2007 |
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients.
Topics: Acetates; Adult; Age Factors; Aged; Calcium; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Chronic Disease; Female; Humans; Kidney Diseases; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Treatment Outcome | 2007 |
Cardiovascular disease-risk factors in middle-aged osteopaenic women treated with calcium alone or combined to three nutrients essential to artery and bone collagen.
Topics: Adult; Ascorbic Acid; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium Carbonate; Calcium, Dietary; Cardiovascular Diseases; Cholesterol; Drug Therapy, Combination; Female; Homocysteine; Humans; Middle Aged; Patient Compliance; Postmenopause; Proline; Pyridoxic Acid; Risk Factors; Vitamin B 6 | 2008 |
5 other study(ies) available for limestone and Cardiovascular Diseases
| Article | Year |
|---|---|
In reply to 'The change history of the INDEPENDENT Study in the ClinicalTrials.gov database'.
Topics: Calcium Carbonate; Cardiovascular Diseases; Female; Humans; Male; Polyamines; Renal Dialysis | 2014 |
The change history of the INDEPENDENT Study in the ClinicalTrials.gov database.
Topics: Calcium Carbonate; Cardiovascular Diseases; Female; Humans; Male; Polyamines; Renal Dialysis | 2014 |
Feasibility of a clinical trial to assess the effect of dietary calcium v. supplemental calcium on vascular and bone markers in healthy postmenopausal women.
Topics: Aged; Biomarkers; Bone and Bones; Calcium Carbonate; Calcium, Dietary; Cardiovascular Diseases; Female; Humans; Middle Aged; Postmenopause | 2016 |
[2 dialysis cases which came to our clinic for the symptoms caused by hypercalcemia].
Topics: Adult; Aged; Calcinosis; Calcium Carbonate; Cardiovascular Diseases; Female; Humans; Hypercalcemia; Kidney Failure, Chronic; Male; Renal Dialysis; Vitamin D | 2005 |
Letter: Mortality and water hardness.
Topics: Australia; Calcium Carbonate; Cardiovascular Diseases; Coronary Disease; Environment; Female; Humans; Male; Middle Aged; Water; Water Supply | 1975 |